Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

MannKind Corp (NASDAQ:MNKD)

1.89
Delayed Data
As of 2:08pm ET
 -0.06 / -3.08%
Today’s Change
1.74
Today|||52-Week Range
10.85
-40.63%
Year-to-Date
3 Companies That Probably Won't Survive Till 2019
Mar 13 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close1.95
Today’s open1.97
Day’s range1.89 - 1.97
Volume578,101
Average volume (3 months)1,115,592
Market cap$186.8M
Dividend yield--
Data as of 2:08pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-163.97%
Earnings growth (next 5 years)+26.80%
Revenue growth (last year)--
P/E ratio1.4
Price/Sales1.68
Price/Book--

Competitors

 Today’s
change
Today’s
% change
KURAKura Oncology Inc-0.13-1.44%
ABEOAbeona Therapeutics ...+0.15+3.19%
PETXAratana Therapeutics...-0.04-0.88%
CLSDClearside Biomedical...-0.09-1.26%
Data as of 2:22pm ET, 03/24/2017

Financials

Next reporting dateMay 15, 2017
EPS forecast (this quarter)-$0.09
Annual revenue (last year)$174.8M
Annual profit (last year)$125.7M
Net profit margin71.91%

Profile

Sector
Health Technology
Industry
Biotechnology
CEO, CFO, Director, VP &
Head-Investor Relations
Matthew J. Pfeffer
Chief Medical Officer &
Vice President
Raymond W. Urbanski
Corporate headquarters
Valencia, California

Forecasts


Search for Jobs